[ad_1]
Twist Bioscience TWST reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Twist Bioscience beat estimated earnings by 17.56%, reporting an EPS of $-1.08 versus an estimate of $-1.31.
Revenue was up $21.09 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.15 which was followed by a 0.8% increase in the share price the next day.
Here’s a look at Twist Bioscience’s past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.28 | -1.06 | -0.79 | -0.75 |
| EPS Actual | -1.13 | -0.91 | -0.84 | -0.78 |
| Revenue Estimate | 45.25M | 38.33M | 37.02M | 32.27M |
| Revenue Actual | 48.13M | 42.02M | 37.95M | 35.02M |
To track all earnings releases for Twist Bioscience visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.